Karyopharm Therapeutics Inc. Quarterly Interest Expense in USD from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Karyopharm Therapeutics Inc. quarterly/annual Interest Expense history and growth rate from Q1 2019 to Q2 2024.
  • Karyopharm Therapeutics Inc. Interest Expense for the quarter ending June 30, 2024 was $8.95M, a 54.7% increase year-over-year.
  • Karyopharm Therapeutics Inc. Interest Expense for the twelve months ending June 30, 2024 was $27.1M, a 15.2% increase year-over-year.
  • Karyopharm Therapeutics Inc. annual Interest Expense for 2023 was $23.8M, a 4.69% decline from 2022.
  • Karyopharm Therapeutics Inc. annual Interest Expense for 2022 was $25M, a 4.03% decline from 2021.
  • Karyopharm Therapeutics Inc. annual Interest Expense for 2021 was $26M, a 4.03% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $27.1M $8.95M +$3.17M +54.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $23.9M $5.88M +$126K +2.19% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $23.8M $6.21M +$323K +5.49% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $23.5M $6.07M -$41K -0.67% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $23.5M $5.78M -$529K -8.38% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $24.1M $5.76M -$926K -13.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $25M $5.89M -$2.06M -25.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $27.1M $6.11M -$1.9M -23.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $28.9M $6.31M +$1.31M +26.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 $27.6M $6.68M +$1.59M +31.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $26M $7.94M +$868K +12.3% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 $25.2M $8.01M +$1.21M +17.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $24M $5M -$1.76M -26% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $25.7M $5.1M -$1.41M -21.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $27.1M $7.07M +$605K +9.36% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-17
Q3 2020 $26.5M $6.8M +$3.71M +120% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $22.8M $6.76M +$3.67M +119% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $19.2M $6.51M +$3.51M +117% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 $15.6M $6.47M Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 $3.09M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-02
Q2 2019 $3.09M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-04
Q1 2019 $3M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.